NEW YORK (GenomeWeb) — Citing increased demand from companies outsourcing freeze-drying of diagnostic kits, molecular diagnostics firm Biofortuna has expanded its PCR reagent lyophilization production service.
NEW YORK (GenomeWeb News) – Trilink BioTechnologies said today that it has inked a new licensing agreement with Biofortuna allowing the UK firm to use Trilink's hot start deoxynucleotides for freeze-drying molecular diagnostic kit development and production service.
NEW YORK (GenomeWeb News) – UK molecular diagnostics firm Biofortuna today announced a £1.3 million investment ($2.0 million), which will go toward the expansion of its custom service and manufacturing business.
NEW YORK (GenomeWeb News) – Becton Dickinson said this week it has declared a quarterly dividend of $45 per share, payable on Sept. 28 to shareholders of record on Sept. 7. The indicated annual dividend rate is $1.80 per share.
Consulting company McKinsey says diagnostics companies will have to combine genomic data analysis, electronic medical records, effective reimbursement strategies, and regulatory compliance in order to win.